Parker Geoffrey M. — SEC insider filings
SEC reporting owner CIK 1491874. 53 insider filings on record with FilingPulse; latest filed 2026-10-23.
Transaction summary — filings shown
Covers the 50 most recent of 53 filings on record, filed 2021-03-08 to 2026-10-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 14 legs across 14 filings — 1,090,495 shares, $2,128,485 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 133,358 shares, $1,951,102 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 75.
- Largest priced transaction: sale of 16,670 shares @ $56.78 ($946,494) in ChemoCentryx, Inc., filed 2021-03-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ChemoCentryx, Inc. (CCXI) | Director | 6 | — | 3 legs · 31,910 sh · $1,806,448 | 20 |
| PERRIGO Co plc (PRGO) | Director | 22 | 8 legs · 42,250 sh · $1,210,589 | — | 35 |
| Better Therapeutics, Inc. (BTTX) | Director | 9 | 5 legs · 1,048,055 sh · $917,212 | — | 5 |
| Allogene Therapeutics, Inc. (ALLO) | CHIEF FINANCIAL OFFICER | 10 | 1 leg · 190 sh · $683 | 4 legs · 101,448 sh · $144,653 | 11 |
| Tricida, Inc. (TCDA) | COO, CFO and EVP | 3 | — | — | 4 |
Insider filings — Parker Geoffrey M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-23 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 36,342 @ $1.34 | EDGAR |
| 2026-09-15 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 1,263 @ $13.66 · Tax withholding (F): 607 @ $13.66 · Option exercise (M): 1,263 (derivative) | EDGAR |
| 2026-06-16 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 976 @ $10.99 · Tax withholding (F): 469 @ $10.99 · Grant/award (A): 844 (derivative) · Option exercise (M): 976 (derivative) | EDGAR |
| 2026-05-15 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 7,305 @ $10.84 · Tax withholding (F): 3,507 @ $10.84 · Grant/award (A): 16,681 (derivative) · Option exercise (M): 7,305 (derivative) | EDGAR |
| 2026-03-17 | 4 | PERRIGO Co plc (PRGO) | Grant/award (A): 3,024 (derivative) | EDGAR |
| 2026-02-04 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 24,001 @ $1.76 · Grant/award (A): 539,072 (derivative) @ $0 · Grant/award (A): 152,480 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | PERRIGO Co plc (PRGO) | Grant/award (A): 2,140 (derivative) | EDGAR |
| 2025-11-14 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 7,500 @ $14.18 | EDGAR |
| 2025-10-23 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 36,744 @ $1.26 | EDGAR |
| 2025-09-16 | 4 | PERRIGO Co plc (PRGO) | Grant/award (A): 1,263 (derivative) | EDGAR |
| 2025-08-20 | 4/A | PERRIGO Co plc (PRGO) | Purchase (P): 4,375 @ $22.97 | EDGAR |
| 2025-08-19 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 4,375 @ $22.97 | EDGAR |
| 2025-06-17 | 4 | PERRIGO Co plc (PRGO) | Grant/award (A): 976 (derivative) | EDGAR |
| 2025-05-16 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 9,904 @ $26.01 · Tax withholding (F): 4,754 @ $26.01 · Grant/award (A): 7,305 (derivative) · Option exercise (M): 9,904 (derivative) | EDGAR |
| 2025-05-14 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 3,500 @ $27.10 | EDGAR |
| 2025-02-05 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 4,361 @ $1.73 | EDGAR |
| 2025-01-28 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 173,913 @ $0 · Grant/award (A): 614,844 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Allogene Therapeutics, Inc. (ALLO) | Tax withholding (F): 36,404 @ $2.84 | EDGAR |
| 2024-05-20 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 344,828 @ $2.90 | EDGAR |
| 2024-05-16 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 8,764 @ $30.22 · Tax withholding (F): 4,207 @ $30.22 · Grant/award (A): 9,904 (derivative) · Option exercise (M): 8,764 (derivative) | EDGAR |
| 2024-03-06 | 4 | Allogene Therapeutics, Inc. (ALLO) | Purchase (P): 190 @ $3.60 | EDGAR |
| 2024-01-31 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 29,400 @ $0 · Grant/award (A): 103,939 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | Better Therapeutics, Inc. (BTTX) | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2023-10-17 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 400,000 @ $0 · Grant/award (A): 390,000 @ $0 · Grant/award (A): 950,000 (derivative) @ $0 | EDGAR |
| 2023-07-31 | 4 | Better Therapeutics, Inc. (BTTX) | Purchase (P): 685,025 @ $0.73 | EDGAR |
| 2023-06-14 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 10,000 @ $33.06 | EDGAR |
| 2023-06-09 | 4 | Better Therapeutics, Inc. (BTTX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 7,778 @ $32.86 · Tax withholding (F): 3,734 @ $32.86 · Option exercise (M): 7,778 (derivative) | EDGAR |
| 2023-05-17 | 4 | PERRIGO Co plc (PRGO) | Grant/award (A): 8,764 (derivative) | EDGAR |
| 2023-04-12 | 4 | Better Therapeutics, Inc. (BTTX) | Purchase (P): 303,030 @ $0.82 | EDGAR |
| 2023-03-07 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 5,000 @ $38.05 | EDGAR |
| 2022-10-24 | 4 | ChemoCentryx, Inc. (CCXI) | Disposition to issuer (D): 107,997 · Disposition to issuer (D): 21,076 · Disposition to issuer (D): 5,000 · Disposition to issuer (D): 8,342 (derivative) · Disposition to issuer (D): 4,504 (derivative) · Disposition to issuer (D): 12,287 (derivative) · +3 more | EDGAR |
| 2022-06-14 | 4 | Better Therapeutics, Inc. (BTTX) | Purchase (P): 25,000 @ $1.45 | EDGAR |
| 2022-06-10 | 4 | Better Therapeutics, Inc. (BTTX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-05-31 | 4 | ChemoCentryx, Inc. (CCXI) | Grant/award (A): 15,723 (derivative) · Grant/award (A): 8,342 (derivative) | EDGAR |
| 2022-05-24 | 4 | ChemoCentryx, Inc. (CCXI) | Option exercise (M): 7,726 @ $0 · Option exercise (M): 7,726 (derivative) | EDGAR |
| 2022-05-19 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 6,599 @ $38.57 · Tax withholding (F): 3,168 @ $38.57 · Grant/award (A): 7,778 (derivative) · Option exercise (M): 6,599 (derivative) | EDGAR |
| 2022-05-03 | 4 | ChemoCentryx, Inc. (CCXI) | Option exercise (M): 12,500 @ $14.42 · Option exercise (M): 12,500 (derivative) | EDGAR |
| 2022-03-31 | 4 | Better Therapeutics, Inc. (BTTX) | Purchase (P): 15,000 @ $2.15 | EDGAR |
| 2022-03-02 | 4 | Tricida, Inc. (TCDA) | Grant/award (A): 256,000 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Tricida, Inc. (TCDA) | Tax withholding (F): 1,384 @ $9.56 | EDGAR |
| 2021-12-17 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 5,000 @ $36.85 | EDGAR |
| 2021-12-16 | 4 | Better Therapeutics, Inc. (BTTX) | Purchase (P): 20,000 @ $4.94 | EDGAR |
| 2021-11-17 | 4 | Tricida, Inc. (TCDA) | Grant/award (A): 166,667 @ $6 · Grant/award (A): 166,667 (derivative) | EDGAR |
| 2021-11-01 | 4 | Better Therapeutics, Inc. (BTTX) | Grant/award (A): 33,333 · Grant/award (A): 28,300 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | ChemoCentryx, Inc. (CCXI) | Gift (G): 4,000 @ $0 · Option exercise (M): 4,660 @ $0 · Grant/award (A): 7,726 (derivative) · Grant/award (A): 4,504 (derivative) · Option exercise (M): 4,660 (derivative) | EDGAR |
| 2021-05-19 | 4 | PERRIGO Co plc (PRGO) | Grant/award (A): 6,599 (derivative) | EDGAR |
| 2021-05-11 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 5,804 @ $42.96 · Tax withholding (F): 2,786 @ $42.96 · Option exercise (M): 5,804 (derivative) | EDGAR |
| 2021-03-18 | 4 | PERRIGO Co plc (PRGO) | Purchase (P): 2,500 @ $41.29 | EDGAR |
| 2021-03-08 | 4 | ChemoCentryx, Inc. (CCXI) | Sale (S): 1,910 @ $60.20 · Sale (S): 16,670 @ $56.78 · Sale (S): 13,330 @ $55.89 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1491874 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs